Outsourcing STREAM

OUTSOURCING

4:33

Outsourcing Clinical Trial Disclosure Management

Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.

47:37

How Sponsors Turn Disclosure As A Service Into A Strategic Advantage

In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.

57:51

Improving Sponsor Oversight Of The Trial Master File

In the face of increasing documentation requirements and trial complexity, discover how global biopharmaceutical company Chiesi and its CRO partners collaborated to ensure ongoing oversight compliance.

7:10

Flipping The Drug Development Industry On Its Head

The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.

0:26

We Are Altasciences: Proactive Drug Development

When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.

1:16

Imagine… Easier, Proactive Drug Development

Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.

0:50

See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada

Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.

9:03

The Heart Of The Matter: Early Vs. Late QT Prolongation Testing

Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.

0:31

Altasciences Has You Covered From Coast To Coast

With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.

0:54

IQVIA Biotech: Clinical Development

Are you preparing to initiate your clinical trial? Trying to get your next milestone quickly? Determining whether to outsource? We can help you answer the questions that keep you up at night.

28:42

The Path Forward, Altasciences' Approach To Project Management

Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.

57:44

How CROs Can Reduce Costs, Drive Retention And Become CRO Of Choice

In this inaugural Phireside webinar of 2024, speakers delve into the pivotal areas where CROs can enhance efficiency and cost-effectiveness.

0:41

Altasciences Clinical Services At A Glance

We can support your entire drug development program end to end, or you can partner with us for just one element. We offer you complete flexibility.

1:00:47

Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments

Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.

3:30

Early Phase Clinical Development Solutions

Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives.

0:43

Proactive Drug Development: Explained

Watch this short video to learn about Proactive Drug Development with Altasciences.

Streamlining Patient Access To Cell And Gene Therapies

Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.

55:25

Navigating The Unique Attributes Of Psychedelic Drug Development

Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.

4:32

Getting Buy-In For Disclosure As A Service

Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.

49:18

How To Boost Disclosure Efficiencies With Outsourcing

In this webinar, you’ll hear about exciting new advisory and managed disclosure services from TrialScope, including: compliance, policy and process assessments, as well as plain-language summaries, protocol registration, results posting, and redaction services.

...

59:40